Literature DB >> 18202101

Normal hypertrophy accompanied by phosphoryation and activation of AMP-activated protein kinase alpha1 following overload in LKB1 knockout mice.

Sean L McGee1, Kirsty J Mustard, D Grahame Hardie, Keith Baar.   

Abstract

The activation of the AMP-activated protein kinase (AMPK) and inhibition of the mammalian target of rapamycin complex 1 (mTORC1) is hypothesized to underlie the fact that muscle growth following resistance exercise is decreased by concurrent endurance exercise. To directly test this hypothesis, the capacity for muscle growth was determined in mice lacking the primary upstream kinase for AMPK in skeletal muscle, LKB1. Following either 1 or 4 weeks of overload, there was no difference in muscle growth between the wild type (wt) and LKB1(-/-) mice (1 week: wt, 38.8 +/- 7.75%; LKB1(-/-), 27.8 +/- 12.98%; 4 week: wt, 75.8 +/- 15.2%; LKB1(-/-), 85.0 +/- 22.6%). In spite of the fact that the LKB1 had been knocked out in skeletal muscle, the phosphorylation and activity of the alpha1 isoform of AMPK were markedly increased in both the wt and the LKB1(-/-) mice. To identify the upstream kinase(s) responsible, we studied potential upstream kinases other than LKB1. The activity of both Ca(2+)-calmodulin-dependent protein kinase kinase alpha (CaMKKalpha) (5.05 +/- 0.86-fold) and CaMKKbeta (10.1 +/- 2.59-fold) increased in the overloaded muscles, and this correlated with their increased expression. Phosphorylation of TAK-1 also increased 10-fold following overload in both the wt and LKB1 mice. Even though the alpha1 isoform of AMPK was activated by overload, there were no increases in expression of mitochondrial proteins or GLUT4, indicating that the alpha1 isoform is not involved in these metabolic adaptations. The phosphorylation of TSC2, an upstream regulator of the TORC1 pathway, at the AMPK site (Ser1345) was increased in response to overload, and this was not affected by LKB1 deficiency. Taken together, these data suggest that the alpha1 isoform of AMPK is preferentially activated in skeletal muscle following overload in the absence of metabolic adaptations, suggesting that this isoform might be important in the regulation of growth but not metabolism.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18202101      PMCID: PMC2327866          DOI: 10.1113/jphysiol.2007.143685

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  46 in total

1.  Exercise induces isoform-specific increase in 5'AMP-activated protein kinase activity in human skeletal muscle.

Authors:  N Fujii; T Hayashi; M F Hirshman; J T Smith; S A Habinowski; L Kaijser; J Mu; O Ljungqvist; M J Birnbaum; L A Witters; A Thorell; L J Goodyear
Journal:  Biochem Biophys Res Commun       Date:  2000-07-14       Impact factor: 3.575

Review 2.  Analysis of the role of the AMP-activated protein kinase in the response to cellular stress.

Authors:  D G Hardie; I P Salt; S P Davies
Journal:  Methods Mol Biol       Date:  2000

3.  Calmodulin-dependent protein kinase kinase-beta is an alternative upstream kinase for AMP-activated protein kinase.

Authors:  Simon A Hawley; David A Pan; Kirsty J Mustard; Louise Ross; Jenny Bain; Arthur M Edelman; Bruno G Frenguelli; D Grahame Hardie
Journal:  Cell Metab       Date:  2005-07       Impact factor: 27.287

4.  Activation of AMP-activated protein kinase increases mitochondrial enzymes in skeletal muscle.

Authors:  W W Winder; B F Holmes; D S Rubink; E B Jensen; M Chen; J O Holloszy
Journal:  J Appl Physiol (1985)       Date:  2000-06

5.  The Ca2+/calmodulin-dependent protein kinase kinases are AMP-activated protein kinase kinases.

Authors:  Rebecca L Hurley; Kristin A Anderson; Jeanne M Franzone; Bruce E Kemp; Anthony R Means; Lee A Witters
Journal:  J Biol Chem       Date:  2005-06-24       Impact factor: 5.157

6.  Effects of alpha-AMPK knockout on exercise-induced gene activation in mouse skeletal muscle.

Authors:  Sebastian B Jørgensen; Jørgen F P Wojtaszewski; Benoit Viollet; Fabrizio Andreelli; Jesper B Birk; Ylva Hellsten; Peter Schjerling; Sophie Vaulont; P Darrell Neufer; Erik A Richter; Henriette Pilegaard
Journal:  FASEB J       Date:  2005-05-05       Impact factor: 5.191

7.  Chronic activation of AMP kinase results in NRF-1 activation and mitochondrial biogenesis.

Authors:  R Bergeron; J M Ren; K S Cadman; I K Moore; P Perret; M Pypaert; L H Young; C F Semenkovich; G I Shulman
Journal:  Am J Physiol Endocrinol Metab       Date:  2001-12       Impact factor: 4.310

8.  AMP kinase is required for mitochondrial biogenesis in skeletal muscle in response to chronic energy deprivation.

Authors:  Haihong Zong; Jian Ming Ren; Lawrence H Young; Marc Pypaert; James Mu; Morris J Birnbaum; Gerald I Shulman
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-20       Impact factor: 11.205

9.  The AMP-activated protein kinase alpha2 catalytic subunit controls whole-body insulin sensitivity.

Authors:  Benoit Viollet; Fabrizio Andreelli; Sebastian B Jørgensen; Christophe Perrin; Alain Geloen; Daisy Flamez; James Mu; Claudia Lenzner; Olivier Baud; Myriam Bennoun; Emmanuel Gomas; Gaël Nicolas; Jørgen F P Wojtaszewski; Axel Kahn; David Carling; Frans C Schuit; Morris J Birnbaum; Erik A Richter; Rémy Burcelin; Sophie Vaulont
Journal:  J Clin Invest       Date:  2003-01       Impact factor: 14.808

10.  Ca2+/calmodulin-dependent protein kinase kinase-beta acts upstream of AMP-activated protein kinase in mammalian cells.

Authors:  Angela Woods; Kristina Dickerson; Richard Heath; Seung-Pyo Hong; Milica Momcilovic; Stephen R Johnstone; Marian Carlson; David Carling
Journal:  Cell Metab       Date:  2005-07       Impact factor: 27.287

View more
  44 in total

Review 1.  AMP-activated protein kinase and its downstream transcriptional pathways.

Authors:  Carles Cantó; Johan Auwerx
Journal:  Cell Mol Life Sci       Date:  2010-07-17       Impact factor: 9.261

2.  Constitutive activation of CaMKKα signaling is sufficient but not necessary for mTORC1 activation and growth in mouse skeletal muscle.

Authors:  Jeremie L A Ferey; Jeffrey J Brault; Cheryl A S Smith; Carol A Witczak
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-08-26       Impact factor: 4.310

Review 3.  Cellular mechanisms regulating protein synthesis and skeletal muscle hypertrophy in animals.

Authors:  Mitsunori Miyazaki; Karyn A Esser
Journal:  J Appl Physiol (1985)       Date:  2008-11-26

4.  Mitochondrial and performance adaptations to exercise training in mice lacking skeletal muscle LKB1.

Authors:  Colby B Tanner; Steven R Madsen; David M Hallowell; Darren M J Goring; Timothy M Moore; Shalene E Hardman; Megan R Heninger; Daniel R Atwood; David M Thomson
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-08-27       Impact factor: 4.310

Review 5.  Adaptations to Endurance and Strength Training.

Authors:  David C Hughes; Stian Ellefsen; Keith Baar
Journal:  Cold Spring Harb Perspect Med       Date:  2018-06-01       Impact factor: 6.915

6.  AMPKγ3 is dispensable for skeletal muscle hypertrophy induced by functional overload.

Authors:  Isabelle Riedl; Megan E Osler; Marie Björnholm; Brendan Egan; Gustavo A Nader; Alexander V Chibalin; Juleen R Zierath
Journal:  Am J Physiol Endocrinol Metab       Date:  2016-01-12       Impact factor: 4.310

Review 7.  Interference between concurrent resistance and endurance exercise: molecular bases and the role of individual training variables.

Authors:  Jackson J Fyfe; David J Bishop; Nigel K Stepto
Journal:  Sports Med       Date:  2014-06       Impact factor: 11.136

8.  Skeletal muscle dysfunction in muscle-specific LKB1 knockout mice.

Authors:  David M Thomson; Chad R Hancock; Bradley G Evanson; Steven G Kenney; Brandon B Malan; Anthony D Mongillo; Jacob D Brown; Squire Hepworth; Natasha Fillmore; Allen C Parcell; David L Kooyman; William W Winder
Journal:  J Appl Physiol (1985)       Date:  2010-04-01

9.  CaMKII regulates contraction- but not insulin-induced glucose uptake in mouse skeletal muscle.

Authors:  Carol A Witczak; Niels Jessen; Daniel M Warro; Taro Toyoda; Nobuharu Fujii; Mark E Anderson; Michael F Hirshman; Laurie J Goodyear
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-03-09       Impact factor: 4.310

10.  A limited role for PI(3,4,5)P3 regulation in controlling skeletal muscle mass in response to resistance exercise.

Authors:  D Lee Hamilton; Andrew Philp; Matthew G MacKenzie; Keith Baar
Journal:  PLoS One       Date:  2010-07-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.